左西孟旦作为杜氏肌营养不良症患者急性心力衰竭的抢救治疗药物
Levosimendan as Rescue Therapy for Acute Heart Failure in a Patient with Duchenne Muscular Dystrophy.
作者信息
Sumanaru Dorin, Josseran Loic, Essid Aben, Mbieleu Blaise, Haegy Isabelle, Bergounioux Jean
机构信息
Pediatric Intensive Care Unit, Hôpital Raymond-Poincaré, APHP, 92380, Garches, France.
Epidemiology Department, Hôpital Raymond-Poincaré, APHP, 92380, Garches, France.
出版信息
Pediatr Cardiol. 2019 Mar;40(3):668-670. doi: 10.1007/s00246-019-02072-9. Epub 2019 Feb 22.
The longer survival of patients with Duchenne muscular dystrophy due to advances in clinical care has increased the incidence of Duchenne muscular dystrophy-associated cardiomyopathy, a nearly consistent feature in the third decade of life. A 26-year-old patient with Duchenne muscular dystrophy experienced severe acute heart failure triggered by pneumonia. Levosimendan was effective in improving heart function.
由于临床护理的进步，杜氏肌营养不良症患者的生存期延长，这增加了杜氏肌营养不良症相关心肌病的发病率，这是在生命的第三个十年中几乎一致出现的特征。一名26岁的杜氏肌营养不良症患者因肺炎引发了严重的急性心力衰竭。左西孟旦在改善心脏功能方面有效。
Zotero 插件